MENU
+Compare
RLYB
Stock ticker: NASDAQ
AS OF
Dec 3, 04:59 PM (EDT)
Price
$0.66
Change
+$0.01 (+1.54%)
Capitalization
27.4M

RLYB Rallybio Corp Forecast, Technical & Fundamental Analysis

Rallybio Corp is a clinical stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare disorders... Show more

RLYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for RLYB with price predictions
Nov 28, 2025

RLYB's RSI Indicator leaves overbought zone

The 10-day RSI Oscillator for RLYB moved out of overbought territory on November 03, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 21 instances where the indicator moved out of the overbought zone. In of the 21 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on RLYB as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for RLYB turned negative on November 17, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RLYB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

RLYB broke above its upper Bollinger Band on October 30, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 60 cases where RLYB's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The 10-day moving average for RLYB crossed bullishly above the 50-day moving average on October 28, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 10 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RLYB advanced for three days, in of 243 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 128 cases where RLYB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.434) is normal, around the industry mean (27.312). P/E Ratio (0.000) is within average values for comparable stocks, (52.442). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.886). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (43.103) is also within normal values, averaging (321.020).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RLYB’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RLYB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
RLYB
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

RLYB is expected to report earnings to fall 142.58% to -15 cents per share on March 17

Rallybio Corp RLYB Stock Earnings Reports
Q4'25
Est.
$-0.15
Q3'25
Beat
by $0.56
Q2'25
Beat
by $0.02
Q1'25
Beat
by $0.07
Q4'24
Beat
by $0.55
The last earnings report on November 06 showed earnings per share of 36 cents, beating the estimate of -20 cents. With 48.66K shares outstanding, the current market capitalization sits at 27.40M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
234 Church Street
Phone
+1 203 859-3820
Employees
43
Web
https://www.rallybio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SMR18.940.86
+4.76%
NuScale Power Corp
HITI2.630.01
+0.57%
High Tide
NGG75.65N/A
N/A
National Grid PLC
OCS18.78-0.22
-1.16%
Oculis Holding AG
MODD0.40-0.02
-5.38%
Modular Medical

RLYB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, RLYB has been loosely correlated with PROK. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if RLYB jumps, then PROK could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLYB
1D Price
Change %
RLYB100%
-0.25%
PROK - RLYB
45%
Loosely correlated
N/A
PXXLF - RLYB
44%
Loosely correlated
N/A
LYEL - RLYB
41%
Loosely correlated
-6.70%
RGNX - RLYB
40%
Loosely correlated
-3.10%
ATXS - RLYB
39%
Loosely correlated
-0.16%
More